Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benoit Chatin"'
Autor:
Stephanie David, Catherine Passirani, Nathalie Carmoy, Marie Morille, Mathieu Mevel, Benoit Chatin, Jean-Pierre Benoit, Tristan Montier, Bruno Pitard
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
We hereby present different DNA nanocarriers consisting of new multimodular systems (MMS), containing the cationic lipid dioleylaminesuccinylparomomycin (DNA MMS DOSP), or bis (guanidinium)-tren-cholesterol (DNA MMS BGTC), and DNA lipid nanocapsules
Externí odkaz:
https://doaj.org/article/0263947d11bb419787d8d6054ee080e0
Autor:
Benoit Chatin, Bruno Pitard, Antoine Magnan, Marie Langelot, Fanny Beilvert, Mathieu Mével, Adrien Tissot, David Lair
Publikováno v:
Human Gene Therapy. 23:597-608
Asthma is a chronic, inflammatory, respiratory disease caused by an abnormal reactivity against allergens. The most promising treatments for asthma are based on specific immunotherapies, but they lack efficiency and can induce deleterious side effect
Publikováno v:
The Biochemical journal. 463(3)
The major cardiac voltage-gated sodium channel Nav1.5 associates with proteins that regulate its biosynthesis, localization, activity and degradation. Identification of partner proteins is crucial for a better understanding of the channel regulation.
Autor:
Raphaël Chèvre, Bruno Pitard, Fanny Beilvert, Mathieu Mével, Olivier Le Bihan, Benoit Barteau, Olivier Lambert, Benoit Chatin
Publikováno v:
Nucleic Acids Research
Amphiphilic block copolymers have been developed recently for their efficient, in vivo transfection activities in various tissues. Surprisingly, we observed that amphiphilic block copolymers such as Lutrol® do not allow the transfection of cultured
Autor:
Benoît Chatin, Mathieu Mével, Julie Devallière, Laurence Dallet, Thomas Haudebourg, Pauline Peuziat, Thibault Colombani, Mathieu Berchel, Olivier Lambert, Aleksander Edelman, Bruno Pitard
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
The intracellular delivery of biologically active protein represents an important emerging strategy for both fundamental and therapeutic applications. Here, we optimized in vitro delivery of two functional proteins, the β-galactosidase (β-gal) enzy
Externí odkaz:
https://doaj.org/article/7ae6901b112f44ed956666a18b9459df